reviewCell MetabolismMay 1, 2009BRONZE OA

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

Merck & Co., Inc., Rahway, NJ, USA (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,033
total citations
FWCI
26.55
Percentile
100%
References
83
Citations per year

Authors

3

Topics & keywords

Keywords
  • AMPK
  • Diabetes mellitus
  • Metabolic syndrome
  • Drug
  • Medicine
  • Metformin
  • Drug discovery
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.